Download presentation
Presentation is loading. Please wait.
Published byHilda Cobb Modified over 5 years ago
1
IPANEMAP Integrative Probing Analysis of Nucleic Acids Empowered by Multiple Accessibility Profiles
Afaf SAAIDI & Yann PONTY Bruno SARGUEIL & Delphine ALLOUCHE CNRS/Ecole Polytechnique Univ. Paris Descartes
2
Structure probing in a nutshell
3
SHAPE + 2D predictions, still below 110%…
RSample, Spasic et al, NAR 2018 David H Mathews
4
The practice of RNA modeling
Probing can be tricky to perform and interpret. Modelers typically use combinations of techniques and reagents, but integration is no gimme… Bruno Sargueil How to integrate multiple probing profiles?
5
A KISS approach Native structure should be represented in each of the pseudo-Boltzmann ensembles (maybe not as MFE) Reactivity profiles uniformly captured as pseudo potentials (aka soft constraints) during sampling (RNAsubopt) ACGAUGAUCGACUACGAUCGA UCGACUAGCUACGUACUGACU CGGCUAGAUUAGCUUAUGA… Sampling (RNAsubopt) Pseudo-Boltzmann
6
IPANEMAP Pipeline
7
Single condition/single structure dataset
IPANEMAP vs Rsample [Spasic et al, NAR 2018] Hajdin et al dataset SHAPE 1M nts RNAs 80% GM IPANEMAP vs 63% GM for Rsample Reason: Rsample ≈ MEA Geometric Mean
8
Multiple conditions improve predictions?
6 RMDB RNAs 5s RNA E. coli Glycine Riboswitch F. Nucleatum cidGMP riboswitch V. Cholerae P4 - P6 domain Tetrahymena ribozyme add Adenine Riboswitch tRNA phenylalanine yeast 3 conditions SHAPE (NMIA) DMS CMCT
9
Back to the lab for even more data
Lariat Capping Ribozyme (PDB 4P8Z) from Didymium iridis Probed under 16 different conditions: It has a pseudoknot Technique: SHAPE, DMS, CMCT Reagents: 1M7, NMIA, DMS, CMCT, NAI, BzCN Stop based and Mutation based readouts Presence/absence Magnesium
10
Mono probing analysis IPANEMAP ≥ MFE, MEA Mutations > Stops
+Mg2+ > -Mg2+ Clear outliers MCC:
11
Mono probing analysis 16 conditions + no-probing (-)
(Squared) Euclidian distance between conditions 16 conditions + no-probing (-) Conditions cluster in 8 groups 2 singletons Outliers confirmed
12
Dual probing analysis Pairs of conditions do not significantly improve predictions but: Mitigate the risk of poor conditions: % MCC on average against worst condition Slightly increase expectation: % avg (+2% median) against mean MCC, +4.4% w/o outliers Sensitive to contamination: % MCC against best, -3.3% w/o outliers
13
Triplets of conditions improve predictions
Considering triplets of conditions (560 triplets) : Improves by 9.1% against worst of triplet Improves by 1.7% vs mean MCC (+6.9% w/o outliers) Some triplets improve overall best MCCs 1M7I-MAPMGIL + 1M7-MAPIL + DMS-CEMG 1M7I-MAPMGIL + 1M7-MAPIL + NMIA-CEMG 1M7I-MAPMGIL + DMS-CEMG + CMCT-CEMG 1M7I-MAPMGIL + 1M7I-MAPIL-3D + BzCN-CEMG Beyond three conditions? → 85.3%MCC
14
The full Monty: Multi probing
All 16 conditions together: 80% MCC (vs 70.5% mono Avg) Within clustered conditions: No info/improvement Across clustered conditions (One condition per cluster) 77% MCC w/o NAI (+6.5) 72% MCC with NAI (+1.5) Orthogonality? Complementarity?
15
Treating mutants as conditions
Mutate-And-Map profiles produced by Das lab (RMDB) Systematic single-point mutants, usually similar structure
16
Conclusion https://github.com/afafbioinfo/IPANEMAP
IPANEMAP is way more than just a pretty acronym Exploits the complementarity of probing experiments Paves the way for quantifying a notion of orthogonality Take home message: Probing remains challenging (accuracy still slightly below 120%...) Having >2 reactivity profiles (even bad ones) appears to help The future: Better pseudo-potentials & clustering procedures Test on multi-stable RNAs Optimal/iterative design of probing experiments
17
Thank you! Ronny Lorenz for modular extensions to Vienna package
Afaf Saaidi Bruno Sargueil Delphine Allouche GaTech/UNC Paris Descartes Ronny Lorenz for modular extensions to Vienna package Soft constraints x Sampling = Awesomeness Supported by Fondation pour la Recherche Médicale
18
Reproducibility
19
2D folding prediction paradigms
Probability/Concentration 0.5 1 B C D A C A B C D D Time A B C D B Enzymatic degradation RNA half life A B C D A B C D A Equilibrium A B C D MFE
Similar presentations
© 2025 SlidePlayer.com Inc.
All rights reserved.